產(chǎn)品名稱 | FITC標(biāo)記的自噬相關(guān)蛋白4A抗體 |
英文名稱 | Anti-ATG4A/FITC |
規(guī)格 | 100ul |
濃度 | 1mg/ml |
價(jià)格 | 來(lái)電可享受優(yōu)惠 |
英文名稱 Anti-ATG4A/FITC
中文名稱 :FITC標(biāo)記的自噬相關(guān)蛋白4A抗體
規(guī)格:100ul
說(shuō)明書 100ul
研究領(lǐng)域腫瘤 免疫學(xué) 細(xì)胞凋亡 轉(zhuǎn)錄調(diào)節(jié)因子
抗體來(lái)源Rabbit
克隆類型Polyclonal
交叉反應(yīng) Human, Mouse, Rat, Cow, Rabbit,
產(chǎn)品應(yīng)用IF=1:50-200
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分子量45kDa
性 狀Lyophilized or Liquid
濃 度1mg/ml
免疫原KLH conjugated synthetic peptide derived from human ATG4A
亞 型IgG
純化方法affinity purified by Protein A
儲(chǔ)存液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件Store at -20 °C for one year.
別 名 ATG4A is a cysteine protease required for autophagy, which cleaves the C-terminal part of either MAP1LC3, GABARAPL2 or GABARAP, allowing the liberation of form I. A subpopulation of form I is subsequently converted to a smaller form (form II). Form II, with a revealed C-terminal glycine, is considered to be the phosphatidylethanolamine (PE)-conjugated form, and has the capacity for the binding to autophagosomes.
